The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults. The system works by sending a message from the pill's sensor to a wearable patch, which then transmits the information to a mobile application so that patients can track the ingestion of the medication on their smartphone. Patients can also permit their caregivers and physician to access the information through a web-based portal.

A year of the pandemic has underscored a critical gap in traditional approaches to keeping Americans healthy. That shortfall is the payer-based health care system's inability to adequately reach patients in their day-to-day lives, where educated choices and lifestyle adjustments can preserve good health and prevent many chronic illnesses.